- Decision-Making Across the Drug Development Continuum: How Does It Align with Your Career Path?
-
Hemisfair Ballroom C3‚ Convention Center
Chair: Xinrong Chen, ABC Toxicology Consulting LLC
Co-Chair: Alema Idrizbegovic, Merck & Co. Inc.
Primary Endorser: Drug Discovery Toxicology Specialty Section
Endorser(s): Graduate Student Leadership Committee
Endorser(s): Career Advancement, Mentoring, and Networking Committee
Drug development often begins with innovative scientific hypotheses and progresses through efficacy and safety data generation, followed by regulatory evaluation before reaching patients. A persistent challenge is that stakeholders across sectors often interpret data using different decision-making frameworks, leading to variability in development strategies and outcomes. Meanwhile, toxicology trainees are increasingly seeking to identify the sector that best fits them and to align their personalities and skills with the demands of different career paths. This session will provide a cross-sector perspective on drug development by bringing together toxicologists from diverse sectors.The presentations will be arranged to follow the sequence of drug development, from research through testing to regulatory approval. The first speaker will discuss key platforms in drug discovery, including genomics, CRISPR, iPSCs, and new approach methodologies (NAMs), as well as examples of “clinical trial in-a-dish” (CTiD) and how these technologies shape early stage biotech and scientific career pathways. The second speaker will address the modernization of toxicology in industry, highlighting how evolving data and regulatory expectations influence decision-making and career development. The third speaker will present perspectives on how safety evaluation is conducted under increasing regulatory demands and accelerated timelines and the competencies required for career advancement in a CRO environment. The fourth speaker will focus on regulatory toxicology and how decisions are made in drug development, along with insights and resources to support regulatory careers. A shared hypothetical drug candidate will serve as a “golden thread” across all presentations to demonstrate how decision-making evolves throughout the drug development continuum. The Chair will provide perspectives on strategic thinking and working styles from a consultant standpoint. The Co-Chair will help synthesize insights across speakers and offer an overarching industry perspective. The panel will also discuss the personality traits and skill sets best suited for their respective sectors, drawing on their own career development and organizational hiring experience to provide actionable insights for trainees and early career professionals.By comparing how different sectors evaluate data, manage uncertainty, and apply decision-making frameworks, this session will provide practical insights and contribute to the development of a conceptual framework describing how decision-making evolves across the drug development continuum. The target audience includes individuals interested in scientific innovation, career entry, professional growth, and career transitions across different sectors. Attendees will gain practical insights into the day-to-day responsibilities of toxicologists across academia, biotech, pharma, CROs, consulting, and the US FDA. Attendees will learn how different sectors evaluate data, how decision-making frameworks evolve across drug development, how transferable skills apply across sectors, and how to identify career environments aligned with their strengths and interests. The session will conclude with an interactive discussion among the panel and the audience. Attendees will have the opportunity to ask questions and gain a clearer understanding of how to navigate their career development by engaging with senior toxicology leaders in drug development.Session and Activity Type
Enter Note
Go to previous page in this tab
Event
